Home About us Editorial board Search Ahead of print Current issue Archives Submit article Instructions Subscribe Contacts Login 
  • Users Online: 672
  • Home
  • Print this page
  • Email this page


 
 Table of Contents  
LETTER TO EDITOR
Year : 2017  |  Volume : 3  |  Issue : 2  |  Page : 93

European Chapter of International Society of Digital Medicine and Clinerion


Head of Marketing and Communications, Clinerion, Switzerland

Date of Web Publication18-Sep-2017

Correspondence Address:
Le Vin Chin
Clinerion, Margarethenstrasse 47, 4053 Basel
Switzerland
Login to access the Email id

Source of Support: None, Conflict of Interest: None


DOI: 10.4103/digm.digm_11_17

Rights and Permissions

How to cite this article:
Chin LV. European Chapter of International Society of Digital Medicine and Clinerion. Digit Med 2017;3:93

How to cite this URL:
Chin LV. European Chapter of International Society of Digital Medicine and Clinerion. Digit Med [serial online] 2017 [cited 2021 Dec 8];3:93. Available from: http://www.digitmedicine.com/text.asp?2017/3/2/93/215023



Dear Editor,

We salute the establishment of the European Chapter of the International Society of Digital Medicine and its publication, the Digital Medicine Journal.

The digitalization of medicine is going to have huge impacts on the cost efficiency of drug development, drug delivery, and patient health in the decades to come. One clear case we can see is the creation huge time and cost savings during the clinical trials of new drugs in development. Today, the recruitment of patients for these trials is a lengthy and inefficient process, taking months and often failing when not enough patients are found.[1],[2] However, imagine if you could find eligible candidates instantaneously by querying digital patient records! This time saving would allow next generation medicines to be evaluated and authorized much quicker, getting them to doctors and patients much earlier.

Operating as we do in the area of big data analytics methodologies to support patient recruitment, market access, and real-world evidence, we can also see very clearly that a consistent and concerted vision is needed for continued success. The case outlined above works best if all healthcare providers have a similarly high level and high quality of digital patient data and if they are all accessible by the same query engine. This vision can only come from a rigorous, but respectful, scientific exchange, and a constructive dialog, all of which are fostering of innovation. We have high hopes therefore for the platform offered by Digital Medicine Journal and look forward to contributing strongly and often and engaging with other contributors.

We wish Digital Medicine Journal and the International Society of Digital Medicine every success, going forward!

Financial support and sponsorship

Nil.

Conflicts of interest

There are no conflicts of interest.



 
  References Top

1.
Beresniak A, Schmidt A, Proeve J, Bolanos E, Patel N, Ammour N, et al. Cost-benefit assessment of using electronic health records data for clinical research versus current practices: Contribution of the Electronic Health Records for Clinical Research (EHR4CR) European Project. Contemp Clin Trials 2016;46:85-91.  Back to cited text no. 1
[PUBMED]    
2.
Tufts Center for the Study of Drug Development: 89% of Trials Meet Enrollment, but Timelines Slip, Half of Sites Under-Enroll, Impact Report. Vol. 15; January/February, 2013.  Back to cited text no. 2
    




 

Top
 
 
  Search
 
Similar in PUBMED
   Search Pubmed for
   Search in Google Scholar for
Access Statistics
Email Alert *
Add to My List *
* Registration required (free)

 
  In this article
References

 Article Access Statistics
    Viewed1649    
    Printed89    
    Emailed0    
    PDF Downloaded165    
    Comments [Add]    

Recommend this journal


[TAG2]
[TAG3]
[TAG4]